Tolebrutinib

Overview

Tolebrutinib (SAR442168) is an orally active, selective, and blood-brain barrier-penetrant BTK inhibitor with neuroactive properties. Tolebrutinib is being investigated for use in multiple sclerosis (MS), particularly secondary progressive multiple sclerosis (SPMS)..

Application

Products | Products > Disease Areas > Multiple Sclerosis | Products > Disease Areas > Experimental Autoimmune Encephalomyelitis | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > CNS Infection | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Experimental Autoimmune Encephalomyelitis | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Neurological Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Btk

Product Information

• Catalog No.: HY-109192
• CAS No.: 1971920-73-6
• Molecular Formula: C26H25N5O3
• Molecular Weight: 455.51
• Purity: 99.12%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (5.49 mM); Clear solution
• Availability: In-stock

Source

Original product source